CCC1(CC)C(=O)C2=C3C1[C@H](C(=O)OC)C=C(C(=O)OC)C[C@H]3n1c(=O)n(-c3ccccc3)c(=O)n1[C@H]2C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?